Fig. 5From: Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma ConsortiumDevelopment of new age-specific prognostic models. The prognostic model for older patients (≥ 65y) was developed in the training cohort (A) and tested in the validation cohort (B); the prognostic model for younger patients (< 65y) was developed in the training cohort (C) and tested in the validation cohort (D)Back to article page